JS
Joseph Stringer Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
79
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
80.7%
Neutral
19.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| – | – | 9 | +32% |
0
%
| 14 Nov ‘25 20 days ago |
|
|
|
Buy
Maintained
| $140 |
14%
upside
| 6 | +2.7% |
0
%
| 13 Nov ‘25 21 days ago |
|
|
|
Buy
Maintained
| $120 |
13%
upside
| 9 | +9.2% |
0
%
| 7 Nov ‘25 27 days ago |
|
|
|
Buy
Maintained
| $90 |
10%
upside
| 9 | +12% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Hold
Downgraded
| $65 |
9%
downside
| 4 | +25% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Hold
Reiterated
| – | – | 1 | – |
–
| 20 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $35 |
13%
upside
| 6 | +37% |
0
%
| 10 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $478 |
3%
upside
| 7 | +12% |
0
%
| 31 Jul ‘25 4 months ago |
|
|
|
Buy
Maintained
| $28 |
91%
upside
| 7 | +22% |
0
%
| 6 Jun ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $14 |
104%
upside
| 3 | -1.2% |
0
%
| 22 May ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $12 |
200%
upside
| 4 | +12% |
0
%
| 16 May ‘25 6 months ago |
|
|
|
Buy
Maintained
| $11 |
144%
upside
| 2 | +64% |
0
%
| 13 May ‘25 6 months ago |
|
|
|
Buy
Maintained
| $29 |
32%
upside
| 1 | +15% |
0
%
| 7 May ‘25 7 months ago |
|
|
|
Hold
Reiterated
| – | – | 4 | – |
–
| 6 May ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $90 |
95%
upside
| 4 | -7.9% |
0
%
| 8 Apr ‘25 8 months ago |
|
|
|
Hold
Reiterated
| – | – | 4 | – |
–
| 7 Mar ‘25 9 months ago |
|
|
|
Hold
Downgraded
| $10 |
669%
upside
| 3 | -58% |
0
%
| 4 Mar ‘25 9 months ago |
|